Daniel Spiegelman
2014
In 2014, Daniel Spiegelman earned a total compensation of $3.2M as Executive Vice President, Chief Financial Officer at BioMarin Pharmaceutical, a 21% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $226,738 |
|---|---|
| Option Awards | $1,588,224 |
| Salary | $480,576 |
| Stock Awards | $870,780 |
| Other | $17,413 |
| Total | $3,183,731 |
Spiegelman received $1.6M in option awards, accounting for 50% of the total pay in 2014.
Spiegelman also received $226.7K in non-equity incentive plan, $480.6K in salary, $870.8K in stock awards and $17.4K in other compensation.
Rankings
In 2014, Daniel Spiegelman's compensation ranked 2,839th out of 13,032 executives tracked by ExecPay. In other words, Spiegelman earned more than 78.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,839 out of 13,032 | 78th |
Division Manufacturing | 1,009 out of 4,967 | 80th |
Major group Chemicals And Allied Products | 322 out of 1,690 | 81st |
Industry group Drugs | 251 out of 1,369 | 82nd |
Industry Pharmaceutical Preparations | 208 out of 1,042 | 80th |
Source: SEC filing on April 25, 2017.
Spiegelman's colleagues
We found four more compensation records of executives who worked with Daniel Spiegelman at BioMarin Pharmaceutical in 2014.
2014
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
2014
Henry Fuchs
BioMarin Pharmaceutical
President, Worldwide R&D
2014
Robert Baffi
BioMarin Pharmaceutical
Executive Vice President, Technical Operations
2014
Jeff Ajer
BioMarin Pharmaceutical